Statistics: Who Gets Hidradenitis Suppurativa?
Written by: Ina Fried | Last reviewed: December 2020
- Mac Mahon J, Kirthi S, Byrne N, et al. An update on health-related quality of life and patient-reported outcomes in hidradenitis suppurativa. Patient Relat Outcome Meas. 2020;11:21-26. http://doi.org/10.2147/PROM.S174299.
- Garg A, Kirby JS, Lavian J, et al. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017 Aug;153:760-764. doi:10.1001/jamadermatol.2017.0201.
- McMillan K. Hidradenitis suppurativa: number of diagnosed patients, demographic characteristics, and treatment patterns in the United States. Am J Epidemiol. 2014;179(12):1477-1483. doi:10.1093/aje/kwu078.
- Dessinioti C, Tzanetakou V, Zisimou C, et al. A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa. Int J Dermatol. 2018 Jun;57(6):687-691. doi:10.1111/ijd.13985. Epub 2018 Mar 31.
- Naik HB, Paul M, Cohen SR, et al. Distribution of self-reported hidradenitis suppurativa age at onset. JAMA Dermatol. 2019 Jun 5;155(8):971-973. doi:10.1001/jamadermatol.2019.0478.
- Napolitano M, Megna M, Timoshchuk EA, et al. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol. 2017;10:105‐115.
- Lee DE, Clark AK, Shi VY. Hidradenitis suppurativa: disease burden and etiology in skin of color. Dermatology 2017;233:456-461. https://doi.org/10.1159/000486741.
- Wertenteil S, Strunk A, Garg A. Association of low socioeconomic status with hidradenitis suppurativa in the United States. JAMA Dermatol. 2018;54(9):1086-1088. Available at https://jamanetwork.com/journals/jamadermatology/fullarticle/2688584.
- Margesson LJ, Danby FW. Hidradenitis suppurativa. Best Pract Res Clin Obstet Gynaecol. 2014 Oct;28:1013-1027. https://doi.org/10.1016/j.bpobgyn.2014.07.012.